Dr. Rapundalo, has broad experience in the life sciences, with an extensive background in pharmaceutical research and development. Prior to joining MichBio in April 2006, he spent almost 20 years as a senior research scientist, project manager, and group leader with Parke-Davis Pharmaceutical Research and then Pfizer, Inc., primarily in the area of cardiovascular drug discovery. Dr. Rapundalo also led a global interdisciplinary team that developed a strategic, operational and organizational change management program to improve Pfizer’s worldwide R&D business processes. He has a strong background in innovation and is an internationally recognized expert in a number of technology areas including high-throughput screening and proteomics, among others.
Dr. Rapundalo has a superb record of scientific achievement with over 50 publications, book chapters, and monographs. He has served as a peer-reviewer for a variety of prominent scientific journals and national funding agencies. In addition, he continues to be active in a broad range of industry and governmental initiatives including intellectual property commercialization, talent recruitment and retention, science education and economic development. Dr. Rapundalo has been a community advocate and civic leader for almost 20 years and formerly served as an elected member of the City Council in Ann Arbor, Michigan.